<?xml version="1.0" encoding="UTF-8"?>
<p>All stakeholders from the pharmaceutical industry, governmental organizations, patient organizations, and the academic world who participated in the steering group and working groups were approached for a semi-structured face-to-face interview with two interviewers (HV, SvD). Per stakeholder, two representatives were present during the interview. In addition, all eight Dutch EUPATI fellows received a questionnaire 
 <italic>via</italic> e-mail to let them add their personal views. Participants in the study thereby represented the perspectives of the patients, governmental bodies, the academic world, and industry. All participants were based in the Netherlands and familiar with the Dutch medicine R&amp;D context. 
 <xref rid="T1" ref-type="table">Table 1</xref> provides an overview of study population: the organizations involved in the interviews and the mission of the organizations.
</p>
